{"nct_id":"NCT03610581","title":"Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2018-09-27","start_date_type":"ACTUAL","primary_completion_date":"2020-10-15","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-15","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["JNJ"]}